Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul-Sep;7(3):177-82.
doi: 10.1016/j.jcot.2016.06.006. Epub 2016 Jun 22.

Mesenchymal stem cell therapy for osteoarthritis

Hassan Afizah  1 , James Hoi Po Hui  1
Affiliations
Review

Mesenchymal stem cell therapy for osteoarthritis

Hassan Afizah et al. J Clin Orthop Trauma. 2016 Jul-Sep.

Abstract

The versatility of mesenchymal stem cells (MSCs) as a treatment modality has landed it another repair target: osteoarthritis, a crippling cartilage disease that frequently afflicts the aged population. Through many studies, this newly discovered method has been shown to significantly alleviate the pain experienced by osteoarthritic patients. Notwithstanding the effectiveness of MSCs in this regard, varying degrees of success rates have also been reported, which is probably attributable to the different approaches adopted in harnessing MSCs' therapeutic value. Accordingly, it is pertinent to understand the contributory factors like MSC type, dosage, size of osteoarthritic lesion, MSC carrier, and mode of infusion, which would be briefly discussed in this review.

Keywords: Dosage; Infusion; Osteoarthritis; Pain; Stem cell.

PubMed Disclaimer

References

    1. Vega A., Martin-Ferrero M.A., Del Canto F. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681–1690. - PubMed
    1. Wong K.L., Lee K.B., Tai B.C., Law P., Lee E.H., Hui J.H. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy. 2013;29(12):2020–2028. - PubMed
    1. Koh Y.G., Kwon O.R., Kim Y.S., Choi Y.J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014;30(11):1453–1460. - PubMed
    1. Wakitani S., Imoto K., Yamamoto T., Saito M., Murata N., Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil. 2002;10(3):199–206. - PubMed
    1. Yamasaki S., Mera H., Itokazu M., Hashimoto Y., Wakitani S. Cartilage repair with autologous bone marrow mesenchymal stem cell transplantation: review of preclinical and clinical studies. Cartilage. 2014;5(4):196–202. - PMC - PubMed

LinkOut - more resources